Aprea Therapeutics (private company)

See something wrong or missing? Let us know
Offices:
Stockholm
Business model:
B2B

Total investments received (USD) - 113.6M

Loading...

Aprea Therapeutics is a clinical-stage biotechnology company developing novel anticancer therapies targeting the p53 tumor suppressor protein

Companies with similar profile to Aprea Therapeutics:

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)